Janney Montgomery Scott LLC purchased a new stake in Cronos Group Inc (NASDAQ:CRON) during the third quarter, according to its most recent 13F filing with the SEC. The firm purchased 15,203 shares of the company’s stock, valued at approximately $169,000.

Several other large investors have also recently added to or reduced their stakes in CRON. FNY Investment Advisers LLC bought a new stake in shares of Cronos Group in the 3rd quarter valued at about $111,000. Tower Research Capital LLC TRC boosted its holdings in shares of Cronos Group by 10,393.4% in the 2nd quarter. Tower Research Capital LLC TRC now owns 17,419 shares of the company’s stock valued at $114,000 after buying an additional 17,253 shares in the last quarter. Stratos Wealth Partners LTD. bought a new stake in shares of Cronos Group in the 3rd quarter valued at about $116,000. Oppenheimer & Co. Inc. bought a new stake in shares of Cronos Group in the 3rd quarter valued at about $121,000. Finally, Exane Derivatives bought a new stake in shares of Cronos Group in the 3rd quarter valued at about $123,000. Institutional investors and hedge funds own 12.42% of the company’s stock.

A number of analysts have recently weighed in on the stock. Zacks Investment Research upgraded shares of Cronos Group from a “hold” rating to a “buy” rating and set a $9.25 price target on the stock in a report on Tuesday, November 6th. Cann initiated coverage on shares of Cronos Group in a research report on Friday, October 12th. They issued a “sell” rating and a $4.50 price objective for the company. Canaccord Genuity raised shares of Cronos Group from a “sell” rating to a “hold” rating in a research report on Wednesday, August 15th. Finally, GMP Securities reaffirmed a “buy” rating on shares of Cronos Group in a research report on Monday, November 19th. One analyst has rated the stock with a sell rating, one has issued a hold rating and three have given a buy rating to the company. The stock currently has a consensus rating of “Hold” and a consensus target price of $7.58.

Shares of Cronos Group stock opened at $10.45 on Friday. Cronos Group Inc has a 52 week low of $3.31 and a 52 week high of $15.30.

Cronos Group (NASDAQ:CRON) last announced its quarterly earnings data on Tuesday, November 13th. The company reported ($0.03) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.02) by ($0.01). The company had revenue of $3.76 million during the quarter, compared to analysts’ expectations of $3.56 million. Cronos Group had a negative net margin of 45.72% and a negative return on equity of 3.22%. The firm’s quarterly revenue was up 187.0% on a year-over-year basis. On average, equities analysts expect that Cronos Group Inc will post -0.04 EPS for the current fiscal year.

ILLEGAL ACTIVITY NOTICE: “Janney Montgomery Scott LLC Purchases New Holdings in Cronos Group Inc (CRON)” was first published by Watch List News and is the property of of Watch List News. If you are viewing this article on another site, it was illegally stolen and reposted in violation of US & international copyright laws. The legal version of this article can be viewed at https://www.watchlistnews.com/janney-montgomery-scott-llc-purchases-new-holdings-in-cronos-group-inc-cron/2667074.html.

Cronos Group Profile

Cronos Group Inc, formerly known as PharmaCan Capital Corp., is a principal investment firm. The firm seeks to invest in companies either licensed, or actively seeking a license, to produce medical marijuana pursuant to Canada's Marihuana for Medical Purposes Regulations “MMPR”. The firm typically invests in companies based in Canada.

Featured Article: Float

Want to see what other hedge funds are holding CRON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cronos Group Inc (NASDAQ:CRON).

Institutional Ownership by Quarter for Cronos Group (NASDAQ:CRON)

Receive News & Ratings for Cronos Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cronos Group and related companies with MarketBeat.com's FREE daily email newsletter.